DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

CLOVIS ONCOLOGY INC (NASDAQ: CLVS)



company name or ticker

Benzinga's Top #PreMarket Losers

Clovis' Lung Cancer Bravado Falls Flat With New Diabetes Revelation

ASCO '14: What's on Tap for Saturday

Clovis Oncology (CLVS) Falls: Stock Goes Down 9.2% - Tale of the Tape

Clovis Gets Breakthrough Therapy Designation - Analyst Blog

Clovis Snags FDA Designation: What's Next?

The coveted breakthrough designation comes through for CO-1686.

Healthcare Stocks Sputtering; Clovis Oncology Gaining After Cancer Treatment Wins Breakthrough Desig

Healthcare Stocks Sputtering; Clovis Oncology Gaining After Cancer Treatment Wins Breakthrough Designation

Sector Update: Healthcare

Benzinga's Top #PreMarket Gainers

Friday's ETF Movers: VWO, XBI

See More Articles...